Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2006Critical CareOpen Access

Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJan O. FriedrichDarmstadt University of Applied SciencesNANeill K. J. AdhikariSunnybrook Health Science CentreMMMaureen O. MeadeMedical Council of Canada

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Friedrich et al. (2006) studied this question.

synapsesocial.com/papers/6a77b0b3137c7dcc81bdfe9ehttps://doi.org/10.1186/cc4947
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Consumer's Guide to Subgroup Analyses1992 · 923 citations
  2. 2Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care2001 · 8,639 citations
  3. 3APACHE II-A Severity of Disease Classification System1986 · 1,252 citations